DGAP-PVR: STADA Arzneimittel AG: Release according to

STADA Arzneimittel AG 23.12.2015 13:14 Dissemination of a Voting Rights Announcement, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Notification of Major Holdings 1. Details of issuer STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany 2. Reason for notification Acquisition/disposal of shares with voting rights X Acquisition/disposal of instruments Change of breakdown of voting rights X Other reason: Delta variation on listed warrants and OTC options 3. Details of person subject to the notification obligation Name: City and country of registered office: Societe Generale S.A. Paris France 4. Names of shareholder(s) holding directly 3% or more voting rights, if different from 3. 5. Date on which threshold was crossed or reached 18.12.2015 6. Total positions % of voting % of voting rights total of total number rights attached through instruments both in % of voting to shares (total (total of 7.b.1 + (7.a. + rights of of 7.a.) 7.b.2) 7.b.) issuer Result- 0,00 % 3,70 % 3,70 % 62342440 ing situat- ion Previo- 0,00 % 5,19 % 5,19 % / us notifi- cation 7. Notified details of the resulting situation a. Voting rights attached to shares (Sec.s 21, 22 WpHG) ISIN absolute in % direct indirect direct indirect (Sec. 21 WpHG) (Sec. 22 WpHG) (Sec. 21 WpHG) (Sec. 22 WpHG) % % Total % b.1. Instruments according to Sec. 25 Abs. 1 Nr. 1 WpHG Type of Expiration or Exercise or Voting Voting instrument maturity date conversion rights rights in period absolute % Certificat- 16.11.2020 until 16.11.2020 1552 0,002 % es Total 1552 0,002 % b.2. Instruments according to Sec. 25 Abs. 1 Nr. 2 WpHG Type of Expiration Exercise or Cash or Voting Voting instrumen- or maturity conversion physical rights rights t date period settlement absolute in % Euro 20.11.2018 until Cash 15691 0,03 % Medium 20.11.2018 Term Note OTC 16.12.2016 until Cash 87462 0,14 % call-opti- 16.12.2016 on OTC 15.12.2017 until Cash 55348 0,09 % call-opti- 15.12.2017 on OTC 21.12.2018 until Cash 1897 0,00 % call-opti- 21.12.2018 on OTC 03.01.2025 until Cash 600000 0,96 % call-opti- 03.01.2025 on Listed 16.12.2016 until Cash 87130 0,14 % call 16.12.2016 warrant Listed 15.12.2017 until Cash 54208 0,09 % call 15.12.2017 warrant Listed 21.12.2018 until Cash 1897 0,00 % call 21.12.2018 warrant Listed 03.01.2025 until Cash 599406 0,96 % call 03.01.2025 warrant Listed 18.03.2016 18.03.2016 Cash 805000 1,29 % call warrant Total 2308039 3,70 % 8. Information in relation to the person subject to the notification obligation Person subject to the notification obligation is not controlled and does itself not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer (1.). X Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity: Name % of voting % of voting rights Total of both rights (if at through instruments (if (if at least least held 3% or at least held 5% or held 5% or more) more) more) Societe % % % Generale S.A. Societe % % % Generale Effekten GmbH 9. In case of proxy voting according to § 22 Abs. 3 WpHG Date of general meeting: Holding position after general meeting: % (equals voting rights) 23.12.2015 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: STADA Arzneimittel AG Stadastraße 2-18 61118 Bad Vilbel Germany Internet: www.stada.de End of Announcement DGAP News-Service ---------------------------------------------------------------------------